Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Aug;51(8):583–587. doi: 10.1136/jcp.51.8.583

Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder.

M F Tungekar 1, J Linehan 1
PMCID: PMC500849  PMID: 9828815

Abstract

AIM: To investigate the patterns of expression of transforming growth factor alpha (TGF-alpha) and epidermal growth factor receptor (EGFR) in squamous metaplasia and squamous cell carcinomas of the urinary bladder with and without schistosomiasis. METHODS: Immunohistochemical study of the expression of TGF-alpha and EGFR in squamous metaplasias (n = 12) and various grades of squamous cell carcinomas (n = 21) of the bladder with and without schistosomiasis. RESULTS: Focal cytoplasmic and membranous positivity for EGFR and TGF-alpha was seen in all cases of squamous metaplasia. The markers were diffusely coexpressed in a concordant pattern in areas of hyperplastic keratinising squamous metaplasia. A similar pattern of positivity was seen in verrucous carcinomas (n = 2) and well differentiated squamous carcinomas (n = 6). Progressive loss of differentiation was associated with increasing loss of EGFR staining while TGF-alpha staining was retained. Squamous cell carcinoma in situ (n = 2) showed focal positivity for TGF-alpha and EGFR. There were no differences in staining patterns between cases with and without schistosomiasis. CONCLUSIONS: The coexpression of TGF-alpha and EGFR by well differentiated squamous cell carcinomas and hyperplastic keratinising squamous metaplasia is consistent with the active regulatory role exerted by this autocrine loop. There is regional absence of expression of EGFR but not of TGF-alpha in squamous cell carcinomas of lesser differentiation, suggesting heterogeneity of such control in these tumours. The focal expression of the two markers in squamous cell carcinomas in situ indicates a possible second pathway of oncogenesis for less differentiated tumours. These observations may have important implications for the effectiveness of putative growth factor based treatments.

Full text

PDF
583

Images in this article

584Image
on p.584
584Image
on p.584
585Image
on p.585
585Image
on p.585
586Image
on p.586
587Image
on p.587
587Image
on p.587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson R. C., Jr, Swanson S. K., Farrow G. M. Relationship of leukoplakia to urothelial malignancy. J Urol. 1984 Mar;131(3):507–511. doi: 10.1016/s0022-5347(17)50469-3. [DOI] [PubMed] [Google Scholar]
  2. Bergler W., Petroianu G., Juncker C., Hörmann K. Correlation of transforming growth factor alpha and epidermal growth factor receptor in oropharyngeal carcinomas. Acta Otolaryngol. 1996 May;116(3):486–489. doi: 10.3109/00016489609137877. [DOI] [PubMed] [Google Scholar]
  3. Eccles S. A., Modjtahedi H., Box G., Court W., Sandle J., Dean C. J. Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy. Invasion Metastasis. 1994;14(1-6):337–348. [PubMed] [Google Scholar]
  4. Ergün S., Zheng X., Carlsö B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol. 1996 May;17(3):393–396. [PubMed] [Google Scholar]
  5. Fukushima S., Ito N., el-Bolkainy M. N., Tawfik H. N., Tatemoto Y., Mori M. Immunohistochemical observations of keratins, involucrin, and epithelial membrane antigen in urinary bladder carcinomas from patients infected with Schistosoma haematobium. Virchows Arch A Pathol Anat Histopathol. 1987;411(2):103–115. doi: 10.1007/BF00712734. [DOI] [PubMed] [Google Scholar]
  6. Gangarosa L. M., Dempsey P. J., Damstrup L., Barnard J. A., Coffey R. J. Transforming growth factor-alpha. Baillieres Clin Gastroenterol. 1996 Mar;10(1):49–63. doi: 10.1016/s0950-3528(96)90039-1. [DOI] [PubMed] [Google Scholar]
  7. Grandis J. R., Tweardy D. J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993 Aug 1;53(15):3579–3584. [PubMed] [Google Scholar]
  8. Grant J. J., Howes G., McKee P. H. Transforming growth factor-alpha expression in in situ epidermal neoplasia. Clin Exp Dermatol. 1995 May;20(3):208–212. doi: 10.1111/j.1365-2230.1995.tb01303.x. [DOI] [PubMed] [Google Scholar]
  9. Groves R. W., Allen M. H., MacDonald D. M. Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours. J Cutan Pathol. 1992 Feb;19(1):66–72. doi: 10.1111/j.1600-0560.1992.tb01561.x. [DOI] [PubMed] [Google Scholar]
  10. Ho T., Horn T., Finzi E. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol. 1991 Aug;127(8):1167–1171. [PubMed] [Google Scholar]
  11. Jasonni V. M., Amadori A., Santini D., Ceccarelli C., Naldi S., Flamigni C. Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFA) expression in different endometrial cancers. Anticancer Res. 1995 Jul-Aug;15(4):1327–1332. [PubMed] [Google Scholar]
  12. Kamel D., Soini Y., Nuorva K., Khalifa A., Mangoud A., Vähäkangas K., Päkkö P. p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions. Virchows Arch. 1994;424(4):349–355. doi: 10.1007/BF00190555. [DOI] [PubMed] [Google Scholar]
  13. Khafagy M. M., el-Bolkainy M. N., Mansour M. A. Carcinoma of the bilharzial urinary bladder. A study of the associated mucosal lesions in 86 cases. Cancer. 1972 Jul;30(1):150–159. doi: 10.1002/1097-0142(197207)30:1<150::aid-cncr2820300122>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  14. Konishi I., Ishikawa Y., Wang S. Y., Wang D. P., Koshiyama M., Mandai M., Komatsu T., Yamamoto S., Mori T. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix. Br J Obstet Gynaecol. 1994 Apr;101(4):325–329. doi: 10.1111/j.1471-0528.1994.tb13619.x. [DOI] [PubMed] [Google Scholar]
  15. Morgan R. J., Cameron K. M. Vesical leukoplakia. Br J Urol. 1980 Apr;52(2):96–100. doi: 10.1111/j.1464-410x.1980.tb02937.x. [DOI] [PubMed] [Google Scholar]
  16. Partridge M., Green M. R., Langdon J. D., Feldmann M. Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation. Br J Cancer. 1989 Oct;60(4):542–548. doi: 10.1038/bjc.1989.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rubin Grandis J., Melhem M. F., Barnes E. L., Tweardy D. J. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 1996 Sep 15;78(6):1284–1292. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  18. Rundle J. S., Hart A. J., McGeorge A., Smith J. S., Malcolm A. J., Smith P. M. Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol. 1982 Oct;54(5):522–526. doi: 10.1111/j.1464-410x.1982.tb13580.x. [DOI] [PubMed] [Google Scholar]
  19. Sakamoto N., Tsuneyoshi M., Enjoji M. Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases. Histopathology. 1992 Aug;21(2):135–141. doi: 10.1111/j.1365-2559.1992.tb00361.x. [DOI] [PubMed] [Google Scholar]
  20. Tungekar M. F., Gatter K. C., Al-Adnani M. S. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract. J Clin Pathol. 1988 Dec;41(12):1288–1296. doi: 10.1136/jcp.41.12.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tungekar M. F., Heryet A., Gatter K. C. The L1 antigen and squamous metaplasia in the bladder. Histopathology. 1991 Sep;19(3):245–250. doi: 10.1111/j.1365-2559.1991.tb00029.x. [DOI] [PubMed] [Google Scholar]
  22. Widran J., Sanchez R., Gruhn J. Squamous metaplasia of the bladder: a study of 450 patients. J Urol. 1974 Oct;112(4):479–482. doi: 10.1016/s0022-5347(17)59765-7. [DOI] [PubMed] [Google Scholar]
  23. Yamamoto T., Ikawa S., Akiyama T., Semba K., Nomura N., Miyajima N., Saito T., Toyoshima K. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature. 1986 Jan 16;319(6050):230–234. doi: 10.1038/319230a0. [DOI] [PubMed] [Google Scholar]
  24. Yoshida K., Kuniyasu H., Yasui W., Kitadai Y., Toge T., Tahara E. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha. J Cancer Res Clin Oncol. 1993;119(7):401–407. doi: 10.1007/BF01218421. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES